Samia Kappe holds a Master of Science in International Management and Marketing from Copenhagen University from 2001 and a SIMI MBA program in Managing Medical Product Innovations from 2006.
Mrs. Kappe joined Novo Nordisk Pharmatech A/S in 2022 as CCO and Director of Sales and Marketing. For more than 20 years, she has taken up regional and global commercial responsibility and held various leadership positions in the pharmaceutical industry, covering sales, marketing, business development, scientific documentation, supply chain, R&D, manufacturing and quality. Prior joining Novo Nordisk Pharmatech A/S, Mrs. Kappe was heading up a CDMO owned by Orifarm, and prior to that, she worked for companies like Lundbeck, Leo Pharma and Coloplast.
Mrs. Kappe is a Danish National, born in 1976.